ARIAD Pharmaceuticals, Inc. ARIA is scheduled to report first-quarter 2016 results on May 10, before the opening bell. The company posted a negative earnings surprise of 14.29% in the fourth quarter of 2015. Let’s see how things are shaping …
ARIAD Pharmaceuticals, Inc. 's ARIA shares surged 72.8% after the company announced a definitive agreement to be acquired by Japan-based Takeda Pharmaceutical Company Limited TKPYY for approximately $5.2 billion. Per the …
High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
Former Democratic presidential candidate Bernie Sanders and U.S. Representative Elijah Cummings issued a letter on …
most recently with its $5.2 billion purchase of Ariad Pharmaceuticals, a US …
Once again, a single tweet on drug pricing resulted in weakness in the biotech sector with ARIAD ARIA losing ground …
The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer-focused ARIAD ARIA for a whopping $5.2 billion. Several other licensing deals and agreements were …